TABLE 6.
Estimated number of cancer death cases by age in Afghanistan's female population, 2020.
| Cancer | Total | 0–14 | 15–39 | 40–44 | 45–49 | 50–54 | 55–59 | 60–64 | 65–69 | 70+ | Crude Rate | ASR (World) | Cum. risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breast | 1783 (22.60%) | 281 | 174 | 203 | 225 | 229 | 216 | 183 | 272 | 9.4 | 17.9 | 3.2 | |
| Cervix uteri | 823 (10.43%) | 1 | 203 | 104 | 110 | 108 | 94 | 77 | 56 | 70 | 4.3 | 7.6 | 1.11 |
| Stomach | 690 (8.74%) | 2 | 41 | 31 | 47 | 70 | 91 | 104 | 103 | 201 | 3.6 | 7.8 | 2.03 |
| Esophagus | 436 (5.53%) | 1 | 36 | 21 | 32 | 43 | 53 | 63 | 65 | 122 | 2.3 | 4.8 | 1.21 |
| Brain, central nervous system | 386 (4.89%) | 47 | 148 | 33 | 33 | 31 | 28 | 23 | 18 | 25 | 2 | 2.9 | 0.39 |
| Liver | 379 (4.80%) | 8 | 39 | 13 | 21 | 31 | 43 | 53 | 57 | 114 | 2 | 4.1 | 1.11 |
| Lung | 356 (4.51%) | 2 | 57 | 23 | 30 | 37 | 42 | 45 | 43 | 77 | 1.9 | 3.7 | 0.82 |
| Ovary | 346 (4.38%) | 4 | 73 | 37 | 45 | 50 | 45 | 38 | 27 | 27 | 1.8 | 3.2 | 0.43 |
| Leukemia | 327 (4.14%) | 96 | 121 | 20 | 19 | 17 | 15 | 13 | 10 | 16 | 1.7 | 2.1 | 0.27 |
| Colorectum | 321 (4.07%) | 35 | 16 | 19 | 27 | 36 | 43 | 49 | 96 | 1.7 | 3.5 | ‐ | |
| Lip, oral cavity | 215 (2.72%) | 3 | 33 | 18 | 22 | 26 | 28 | 28 | 23 | 34 | 1.1 | 2.1 | 0.38 |
| Corpus uteri | 185 (2.34%) | 22 | 16 | 20 | 22 | 26 | 26 | 24 | 29 | 0.98 | 1.9 | 0.31 | |
| Non‐Hodgkin lymphoma | 164 (2.08%) | 16 | 56 | 14 | 14 | 14 | 13 | 12 | 9 | 16 | 0.87 | 1.3 | 0.21 |
| Pancreas | 136 (1.72%) | 17 | 7 | 9 | 13 | 17 | 20 | 19 | 34 | 0.72 | 1.5 | 0.35 | |
| Kidney | 112 (1.42%) | 23 | 14 | 6 | 8 | 10 | 11 | 13 | 11 | 16 | 0.59 | 1 | 0.17 |
| Gallbladder | 70 (0.89%) | 4 | 4 | 6 | 8 | 10 | 11 | 10 | 17 | 0.37 | 0.77 | 0.18 | |
| Thyroid | 46 (0.58%) | 2 | 5 | 1 | 3 | 5 | 6 | 7 | 7 | 10 | 0.24 | 0.48 | 0.09 |
| Multiple myeloma | 46 (0.58%) | 11 | 6 | 2 | 6 | 4 | 5 | 4 | 8 | 0.24 | 0.43 | 0.08 | |
| Hodgkin lymphoma | 40 (0.51%) | 6 | 22 | 1 | 1 | 3 | 2 | 2 | 2 | 1 | 0.21 | 0.25 | 0.03 |
| Bladder | 39 (0.49%) | 3 | 4 | 2 | 3 | 4 | 5 | 4 | 5 | 9 | 0.21 | 0.39 | 0.07 |
| Larynx | 37 (0.47%) | 7 | 3 | 8 | 6 | 4 | 4 | 2 | 3 | 0.2 | 0.36 | 0.07 | |
| Melanoma of skin | 31 (0.39%) | 7 | 3 | 2 | 3 | 4 | 3 | 2 | 7 | 0.16 | 0.31 | 0.08 | |
| Oropharynx | 27 (0.34%) | 2 | 2 | 2 | 4 | 3 | 3 | 3 | 4 | 4 | 0.14 | 0.27 | 0.04 |
| Nasopharynx | 26 (0.33%) | 1 | 13 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 0.14 | 0.2 | 0.03 |
| Hypopharynx | 26 (0.33%) | 7 | 3 | 3 | 2 | 2 | 2 | 2 | 5 | 0.14 | 0.24 | 0.05 | |
| Vulva | 24 (0.30%) | 1 | 4 | 3 | 2 | 3 | 4 | 7 | 0.13 | 0.27 | 0.06 | ||
| Vagina | 15 (0.19%) | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 0.08 | 0.15 | 0.03 | |
| Salivary glands | 16 (0.20%) | 3 | 1 | 1 | 1 | 1 | 3 | 2 | 4 | 0.08 | 0.16 | 0.04 | |
| Kaposi sarcoma | 6 (0.08%) | 1 | 1 | 1 | 1 | 1 | 1 | 0.03 | 0.06 | 0.01 | |||
| Mesothelioma | 3 (0.04%) | 1 | 1 | 1 | 0.02 | 0.04 | 0.01 | ||||||
| All cancers excluding non‐melanoma skin cancer | 7905 (100.18%) | 340 | 340 (3.32%) | 1422 (13.88%) | 617 (6.02%) | 740 (7.22%) | 850 (8.30%) | 900 (8.78%) | 902 (8.80%) | 809 (7.90%) | 41.7 | 76.7 | 13.91 |
Note: *The incidence, prevalence proportions (prop.), crude rates, and ASR were reported per 100 000 people.